These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6449332)

  • 1. Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Buschard K; Madsbad S; Rygaard J
    Clin Exp Immunol; 1980 Jul; 41(1):25-32. PubMed ID: 6449332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus: a prospective study.
    Buschard K; Madsbad S; Rygaard J
    J Clin Lab Immunol; 1982 May; 8(1):19-23. PubMed ID: 6212684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.
    Buschard K; Röpke C; Madsbad S; Mehlsen J; Sørensen TB; Rygaard J
    J Clin Lab Immunol; 1983 Mar; 10(3):127-31. PubMed ID: 6221108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective suppressor cell generation in juvenile onset diabetes.
    Lederman MM; Ellner JJ; Rodman HM
    J Immunol; 1981 Nov; 127(5):2051-5. PubMed ID: 6457859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus.
    Buschard K; Madsbad S; Krarup T; Rygaard J
    Clin Exp Immunol; 1982 Apr; 48(1):189-95. PubMed ID: 7044628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay.
    Buschard K; Madsbad S; Rygaard J
    J Clin Lab Immunol; 1983 Jul; 11(3):123-8. PubMed ID: 6224937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.
    Horita M; Suzuki H; Onodera T; Ginsberg-Fellner F; Fauci AS; Notkins AL
    J Immunol; 1982 Oct; 129(4):1426-9. PubMed ID: 6213714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor cell activity and beta-cell function in insulin-dependent diabetics.
    Buschard K; Madsbad S; Rygaard J
    Acta Pathol Microbiol Immunol Scand C; 1982 Apr; 90(2):53-7. PubMed ID: 6211031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thymosin and insulin on suppressor T cell in type 1 diabetes.
    Wang SH; Chen G; Zhang K
    Diabetes Res; 1992 Jan; 19(1):21-9. PubMed ID: 1468183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS; Kyner JL; Abdou NI
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
    Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis.
    Jensen JR; Cramers M; Thestrup-Pedersen K
    Clin Exp Immunol; 1981 Jul; 45(1):118-23. PubMed ID: 6458433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.
    de Galocsy C; Jenkins PJ; Mieli-Vergani G; Eddleston AL; Williams R
    Clin Exp Immunol; 1981 Mar; 43(3):486-90. PubMed ID: 6456855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor leukocytes in anergic patients with solid tumors.
    Bankhurst AD; Kauffman GR; Goodwin JS; Saiki JH; Saiers JH; Williams RC
    J Clin Lab Immunol; 1980 May; 3(3):159-63. PubMed ID: 6448298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus.
    Buschard K; Madsbad S
    J Clin Lab Immunol; 1984 Feb; 13(2):65-70. PubMed ID: 6327989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.